Systematic screening for advanced liver fibrosis in patients with coronary artery disease: The CORONASH study
Résumé
Although coronary artery disease (CAD) and advanced liver fibrosis (AdLF) are commonly associated in patients with non-alcoholic fatty liver disease (NAFLD), the prevalence of AdLF and the diagnostic performance of non-invasive fibrosis tests (NITs) in CAD patients remains unknown. We aimed to prospectively screen for AdLF in patients with documented CAD using NITs and Fibroscan. High and intermediate zones of NITs were combined to define AdLF. AdLF was suspected whenever APRI ≥ 0.5, Forns index ≥ 4.2, NAFLD fibrosis score (NFS) ≥ -1.455/0.12 for age
Domaines
Sciences du Vivant [q-bio]Véronique BOURGEAIS : Connectez-vous pour contacter le contributeur
https://univ-angers.hal.science/hal-03789232
Soumis le : mardi 27 septembre 2022-12:02:44
Dernière modification le : jeudi 18 janvier 2024-10:28:20
Citer
Thierry Thévenot, Sophie Vendeville, Delphine Weil, Linda Akkouche, Paul Calame, et al.. Systematic screening for advanced liver fibrosis in patients with coronary artery disease: The CORONASH study. PLoS ONE, 2022, 17 (5), pp.e0266965. ⟨10.1371/journal.pone.0266965⟩. ⟨hal-03789232⟩
Collections
14
Consultations
0
Téléchargements